Cancer cells, which display a higher metabolic rate and consequently experience more ROS production, upregulate NRF2 to counter the elevated oxidative stress while exploiting ROS for cancer cell signaling and disease progression [36,64,75]. Here, NFE2L2 is linked to cancer.